LYRA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lyra Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.495 USD -62.5% Market Closed

Market Cap: $443.7k

	Lyra Therapeutics Inc OTC:LYRA	US
	Esta Multi Usaha Tbk PT IDX:ESTA	ID
G	Global Energy Ventures Ltd OTC:GBBLF	AU
K	KST Beteiligungs AG DUS:KSW	DE

Profitability Summary

Lyra Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-7.425%

Negative 3Y Average Operating Margin

-4.694%

Declining Operating Margin

-4.910% > -7.425%

Negative Net Margin

-7.266%

Negative 3Y Average Net Margin

-5.530%

Declining Net Margin

-4.910% > -7.266%

Negative Free Cash Flow Margin

-7.280%

Negative 3Y Average Free Cash Flow Margin

-5.035%

Declining Free Cash Flow Margin

-4.299% > -7.280%

Negative ROE

-6.595%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-282%

ROIC is Increasing

-945% > -134%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.